Author(s): M. Alonso and A. Martinez Affiliation: NeuroPharma, S.A.; Avda. De la Industria 52, 28760 Tres Cantos, Madrid, Spain. - See more at: http://www.eurekaselect.com/61839/article?trendmd-shared=0#sthash.g4m4RuEA.dpuf 2. The Possible Involvement of Glycogen Synthase Kinase-3 (GSK-3) in Diabetes, Cancer and Central Nervous System Diseases Author(s): Amar S., Belmaker R.H. and Agam G. Affiliation: Beer-Sheba Mental Health Center PO Box 4600, Beer-Sheba ISRAEL. - See more at: http://www.eurekaselect.com/74966/article#sthash.JDwG8T1e.dpuf 3. Structure-Based Approaches in the Design of GSK-3 Selective Inhibitors Author(s): Dhilon S. Patel, Nigus Dessalew, Pansy Iqbal and Prasad V. Bharatam Affiliation: Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar (Mohali) - 160 062, Punjab, India. - See more at: http://www.eurekaselect.com/78567/article?trendmd-shared=0#sthash.hW02mw4r.dpuf 4. Exploiting Substrate Recognition for Selective Inhibition of Protein Kinases Author(s): Avital Licht-Murava and Hagit Eldar-Finkelman Affiliation: Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel. - See more at: http://www.eurekaselect.com/98470/article?trendmd-shared=0#sthash.jKbAUWDl.dpuf 5. Glycogen Synthase Kinase-3 - An Overview of An Over-Achieving Protein Kinase Author(s): Lisa Kockeritz, Bradley Doble, Satish Patel and James R. Woodgett Affiliation: Samuel Lunenfeld Research Institute, 600 University Avenue, Ontario M5G 1X5, Canada.
- See more at: http://www.eurekaselect.com/58133/article?trendmd-shared=0#sthash.PKemuRlI.dpuf